Upexi, Inc. Form 8-K Summary
Business Context and Reporting Period
Upexi, Inc. filed a Current Report on Form 8-K dated April 2, 2024, concerning a Nasdaq continued-listing deficiency. The company’s common stock trades under the symbol UPXI on Nasdaq Capital Market.
Key Financial and Listing Metrics
- Nasdaq reported that Upexi’s common stock closed below the $1.00 minimum bid price for 30 consecutive business days.
- The filing does not provide revenue, profit, cash flow, margin, debt, cash, or liquidity figures.
- The deficiency relates to Nasdaq Listing Rule 5550(a)(2), the Minimum Bid Price Requirement.
Material Change and Compliance Status
Upexi received Nasdaq’s bid price deficiency letter on April 1, 2024. The company received an initial 180-calendar-day compliance period ending September 30, 2024, to regain compliance. As of the filing date, compliance had not been restored.
The notice had no immediate effect on the listing or trading of the common stock.
Outlook, Risks, and Unusual Items
Upexi stated that it intends to monitor its stock price and evaluate available measures to regain compliance, including a reverse stock split if necessary.
If the company satisfies Nasdaq’s other applicable initial-listing requirements, including the market value of publicly held shares requirement, it may be eligible for an additional 180-day compliance period. If Nasdaq determines that Upexi is not eligible or is unlikely to cure the deficiency, the shares could be subject to delisting. The company may appeal a delisting determination to the Nasdaq Hearings Panel, although continued listing cannot be assured.
The filing identifies risks including insufficient capital, potential stockholder dilution, dependence on management, competition, regulatory changes, financing availability, execution of the growth strategy, and other risks described in the company’s prior SEC filings.
Investor Verification Items
- Verify whether Upexi regained compliance with Nasdaq’s $1.00 minimum bid price requirement by September 30, 2024.
- Monitor whether Nasdaq granted an additional compliance period or issued a delisting notice.
- Review any subsequent disclosure regarding a reverse stock split or other corrective action.
- Assess the company’s cash position, financing needs, debt, and dilution risk using its latest periodic filings.
- Review subsequent SEC filings for developments affecting Nasdaq eligibility and operating results.